新生儿甲状腺功能亢进症与长效甲状腺刺激素保护剂
Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
作者信息
Nutt J, Clark F, Welch R G, Hall R
出版信息
Br Med J. 1974 Dec 21;4(5946):695-6. doi: 10.1136/bmj.4.5946.695.
Abstract
Neonatal hyperthyroidism has been thought to result from transplacental passage of long-acting thyroid stimulator (L.A.T.S.) from a mother with Graves's disease. A case is presented here in which no L.A.T.S. was detected in the mother or neonate but another immunoglobulin, L.A.T.S. protector, a specific human thyroid stimulator, was shown to be present in the mother's serum. This stimulator may have been the cause of the neonatal hyperthyroidism.
摘要
新生儿甲状腺功能亢进症一直被认为是由于长效甲状腺刺激素（LATS）通过胎盘从患有格雷夫斯病的母亲传递给胎儿所致。本文报告了一例病例，在母亲和新生儿体内均未检测到LATS，但发现母亲血清中存在另一种免疫球蛋白——LATS保护因子，一种特异性人类甲状腺刺激素。这种刺激素可能是导致新生儿甲状腺功能亢进症的原因。
相似文献
1
Neonatal hyperthyroidism and long-acting thyroid stimulator protector.新生儿甲状腺功能亢进症与长效甲状腺刺激素保护剂
Br Med J. 1974 Dec 21;4(5946):695-6. doi: 10.1136/bmj.4.5946.695.
2
The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.
Br J Obstet Gynaecol. 1978 Nov;85(11):837-43. doi: 10.1111/j.1471-0528.1978.tb15839.x.
3
["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].["长效甲状腺刺激素"与新生儿甲状腺毒症中的促甲状腺激素]
Schweiz Med Wochenschr. 1968 Jan 6;98(1):8-12.
4
Neonatal hyperthyroidism in an infant born of an euthyroid mother.甲状腺功能正常的母亲所生婴儿的新生儿甲状腺功能亢进症。
Am J Dis Child. 1971 May;121(5):440-3. doi: 10.1001/archpedi.1971.02100160110019.
5
[Etiology of hyperthyroidism].[甲状腺功能亢进症的病因]
Schweiz Med Wochenschr. 1967 Oct 14;97(41):1342-52.
6
Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).新生儿甲状腺毒症与人类甲状腺刺激免疫球蛋白（HTSI）经胎盘传递有关。
Arch Dis Child. 1976 Jul;51(7):565-7. doi: 10.1136/adc.51.7.565.
7
8
Letter: Placental transmission of L. A. T. S. protector.信件：长效甲状腺刺激素保护因子的胎盘传播。
Lancet. 1974 Dec 28;2(7896):1579-80. doi: 10.1016/s0140-6736(74)90335-3.
9
Neonatal thyrotoxicosis: a rare pediatric emergency.新生儿甲状腺毒症：一种罕见的儿科急症。
Ann Emerg Med. 1980 Nov;9(11):585-7. doi: 10.1016/s0196-0644(80)80231-9.
10
THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.甲状腺疾病中促甲状腺素和长效甲状腺刺激素检测
J Clin Endocrinol Metab. 1965 Feb;25:189-208. doi: 10.1210/jcem-25-2-189.
引用本文的文献
1
Thyrotoxicosis in a neonate of a mother with no history of thyroid disease.母亲无甲状腺疾病史的新生儿甲状腺毒症
Arch Dis Child. 1976 Apr;51(4):314-6. doi: 10.1136/adc.51.4.314.
2
Editorial: hyperthyroidism and Grave's disease.社论：甲状腺功能亢进症与格雷夫斯病
Br Med J. 1975 May 31;2(5969):457-8. doi: 10.1136/bmj.2.5969.457.
3
Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).新生儿甲状腺毒症与人类甲状腺刺激免疫球蛋白（HTSI）经胎盘传递有关。
Arch Dis Child. 1976 Jul;51(7):565-7. doi: 10.1136/adc.51.7.565.
4
Pathogenesis of neonatal Graves' disease.新生儿Graves病的发病机制。
J Endocrinol Invest. 1978 Apr;1(2):183-9. doi: 10.1007/BF03350370.
5
Immunological studies in the neonate of a mother with Addison's disease and diabetes mellitus.对患有艾迪生病和糖尿病的母亲的新生儿进行的免疫学研究。
Clin Exp Immunol. 1977 Apr;28(1):192-5.
本文引用的文献
1
Neonatal hyperthyroidism.
N Engl J Med. 1963 Feb 7;268:292-6. doi: 10.1056/NEJM196302072680606.
2
Evidence to suggest that LATS protector stimulates the human thyroid gland.有证据表明LATS保护剂会刺激人体甲状腺。
J Clin Endocrinol Metab. 1971 Jul;33(1):47-51. doi: 10.1210/jcem-33-1-47.
3
Radioimmunoassay of human serum thyrotrophin.人血清促甲状腺素的放射免疫测定
Br Med J. 1971 Mar 13;1(5749):582-5. doi: 10.1136/bmj.1.5749.582.
4
The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro.长效甲状腺刺激素（LATS）与甲状腺组织的体外相互作用。
J Endocrinol. 1970 Jan;46(1):45-54. doi: 10.1677/joe.0.0460045.
5
Direct evidence for human thyroidal stimulation by LATS-protector.长效甲状腺刺激素保护物对人体甲状腺刺激的直接证据。
J Clin Endocrinol Metab. 1973 Mar;36(3):517-21. doi: 10.1210/jcem-36-3-517.
6
Graves' disease--1972.格雷夫斯病——1972年。
Mayo Clin Proc. 1972 Nov;47(11):803-13.
7
Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.甲状腺毒症中出现一种γ球蛋白，它可保护长效甲状腺刺激素不被甲状腺提取物中和。
J Clin Endocrinol Metab. 1967 Feb;27(2):173-7. doi: 10.1210/jcem-27-2-173.
8
Neonatal thyrotoxicosis associated with maternal hypothyroidism.与母体甲状腺功能减退相关的新生儿甲状腺毒症。
Lancet. 1966 Mar 19;1(7438):635-6. doi: 10.1016/s0140-6736(66)90828-2.
9
Grades of hypothyroidism.甲状腺功能减退的分级。
Br Med J. 1973 Mar 17;1(5854):657-62. doi: 10.1136/bmj.1.5854.657.
10
Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).LATS是否会导致格雷夫斯病中的甲状腺功能亢进？（一篇倾向于肯定回答的综述）
Metabolism. 1972 Sep;21(9):883-94. doi: 10.1016/0026-0495(72)90012-1.
Zotero 插件